Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
US Army
McKesson
Argus Health
Moodys
Fish and Richardson
Express Scripts
Chubb
McKinsey
Farmers Insurance

Generated: February 21, 2018

DrugPatentWatch Database Preview

ALUPENT Drug Profile

« Back to Dashboard

Which patents cover Alupent, and when can generic versions of Alupent launch?

Alupent is a drug marketed by Boehringer Ingelheim and is included in five NDAs.

The generic ingredient in ALUPENT is metaproterenol sulfate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the metaproterenol sulfate profile page.

US Patents and Regulatory Information for ALUPENT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim ALUPENT metaproterenol sulfate AEROSOL, METERED;INHALATION 016402-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate TABLET;ORAL 015874-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate SOLUTION;INHALATION 017659-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate SOLUTION;INHALATION 018761-002 Oct 10, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate SOLUTION;INHALATION 018761-001 Jun 30, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate TABLET;ORAL 015874-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate SYRUP;ORAL 017571-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ALUPENT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim ALUPENT metaproterenol sulfate AEROSOL, METERED;INHALATION 016402-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate SYRUP;ORAL 017571-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate TABLET;ORAL 015874-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate TABLET;ORAL 015874-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate SOLUTION;INHALATION 018761-001 Jun 30, 1983 ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate SOLUTION;INHALATION 017659-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Merck
Chubb
Cerilliant
Julphar
Express Scripts
Argus Health
Mallinckrodt
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot